Trial Profile
A Randomized, Two-way Crossover Study to Compare the Bioavailability of 300 mg Trazodone Hydrochloride Extended-release Caplets (Containing Contramid) (Administered as a Single Dose) and 100 mg Trazodone Hydrochloride Immediate-release Tablets (Administered Three Times Daily) Under Fasting Conditions.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 May 2012
Price :
$35
*
At a glance
- Drugs Trazodone (Primary)
- Indications Anxiety disorders; Depressive disorders
- Focus Pharmacokinetics
- Sponsors Altus Formulation Inc
- 14 May 2010 New trial record